Merck CEO Says Company Expects To Continue To See A Decline In Gardasil Shipments Into China Into 2025; Says Co Sees 2025 Market Opportunity For Gardasil In China In The $2B To $3B Range, Driven By Opportunity For Use In Males
Portfolio Pulse from Benzinga Newsdesk
Merck's CEO announced that the company anticipates a continued decline in Gardasil shipments to China until 2025. However, Merck sees a market opportunity for Gardasil in China valued between $2 billion to $3 billion by 2025, driven by potential use in males.
October 31, 2024 | 1:44 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Merck anticipates a decline in Gardasil shipments to China until 2025, but sees a significant market opportunity valued at $2B-$3B by then, driven by male usage.
The news indicates a short-term decline in Gardasil shipments, which could negatively impact revenues. However, the long-term market opportunity in China, especially with male usage, suggests potential future growth. This balances the short-term impact, resulting in a neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100